MedPath

Evaluation of Topical Sertaconazole Efficacy with Cryotherapy versus Cryotherapy with placebo in Treatment of Cutaneous Leishmaniasis

Phase 3
Conditions
Cutaneus Leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT20180623040195N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients above 12 years old
Numbers of lesions are less than 3
Diameter of the lesions are less than 3 cm
Positive smear for leishmaniasis
Less than 4 months from the onset of the lesion

Exclusion Criteria

Pregnant and lactating women
Unwillingness to participate in the study
Known cases of systemic diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area of the lesion. Timepoint: The 0, 2, 4 and 8 weeks. Method of measurement: Using the rule and measurement of the diameters of lesion.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath